Classification
In the literature, Somatropin (recombinant Human Growth Hormone, rHGH) is classified as a 191-amino-acid hormone analogue with mapped binding to the GHR receptor. The presentation is RUO and concerns laboratory GH-axis models.
Markers and receptor signalling
The literature discusses it in relation to GHR, JAK2/STAT5, MAPK and PI3K/Akt signalling pathways, and to GH/IGF-1 axis markers in laboratory models. The reading concerns receptor mapping and hormonal classification, not outcome claims.
Thematic mapping
Related research categories: the GH-axis literature framework, GHR receptor signalling, and laboratory markers of hormonal classification in research models.
RUO note
This article is an informational overview of the literature classification of RUO materials. It provides no directions for use, application amounts, protocols or outcome claims. For laboratory research use only. Not for human or veterinary use.